Caxton Associates (UK)’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.38M Buy
+1,216,631
New +$4.13M 0.12% 58
2025
Q2
– Sell
-445,512
Closed -$1.6M – 712
2025
Q1
$1.6M Buy
+445,512
New +$1.79M 0.06% 217

Other funds holding CLOV

Caxton Associates (UK)'s CLOV Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Clover Health Investments (CLOV) in Q2 2026: 1,216,631 shares worth $6.38M. The stake represents 0.12% of the portfolio and ranks #58 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in CLOV as recently as Q1 2025.

Caxton Associates (UK) first reported a position in CLOV in Q1 2025 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Caxton Associates (UK) held 1,216,631 shares of Clover Health Investments worth $6.38M as of Q2 2026.
  • Clover Health Investments was a new Caxton Associates (UK) position in Q2 2026.
  • Clover Health Investments made up 0.12% of Caxton Associates (UK)'s portfolio in Q2 2026, its #58 holding.
  • Caxton Associates (UK) first reported a position in Clover Health Investments in Q1 2025 and has held it in 2 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.